A comparison of outcome in patients with Stage 1 clear cell and grade 3 endometrioid adenocarcinoma of the endometrium with and without adjuvant therapy

European Journal of Gynaecological Oncology

Volumn 31, Issue 3, 2010, Pages 284-287

  Rauh Hain, J A ^a   Costaaggini, I ^b   Olawaiye, A B ^c   Growdon, W B ^a   Horowitz, N S ^b   Del Carmen, M G ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Endometrioid adenocarcinoma of the endometrium; Radiotherapy; Uterine cancer; Uterine clear cell carcinoma

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BRACHYTHERAPY; CANCER ADJUVANT THERAPY; CANCER DIAGNOSIS; CANCER GRADING; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE FREE SURVIVAL; ENDOMETRIUM CARCINOMA; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; UTERINE CLEAR CELL CARCINOMA; UTERUS CARCINOMA;

ADENOCARCINOMA, CLEAR CELL; AGED; AGED, 80 AND OVER; CARCINOMA, ENDOMETRIOID; CASE-CONTROL STUDIES; CHEMOTHERAPY, ADJUVANT; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; RADIOTHERAPY, ADJUVANT;

EID: 77954119181     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. www.cancer.org. Cancer Facts and Figures, 2008.
2. Kurman R.J., Scully R.E.: "Clear cell carcinoma of the endometrium: an analysis of 21 cases". Cancer, 1976; 37, 872.
3. de Boneville H.E.: "Uber einege Falle von Carcinoma Corporis Uteri mit viel Glycogen". Virchow's Arch. Pathol. Anat., 1911, 204, 201.
4. Christopherson W.M., Alberhasky R.C., Connelly P.J.: "Carcinoma of the endometrium: A clinicopathologic study of clear-cell carcinoma and secretory carcinoma". Cancer, 1982, 49, 1511.
5. Cirisano F.D. Jr., Robboy S.J., Dodge R.K., Bentley R.C., Krigman H.R., Synan I.S. et al.: "The outcome of Stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma". Gynecol. Oncol., 2000, 77, 55.
6. Thomas M., Mariani A., Wright J.D., Madarek E.O., Powell M.A., Mutch D.G. et al.: "Surgical management and adjuvant therapy for patients with uterine clear cell carcinoma: a multi-institutional review". Gynecol. Oncol., 2008, 108, 293.
7. Creasman W.T., Odicino F., Maisonneuve P., Beller U., Benedet J.L., Heintz A.P. et al.: "Carcinoma of the corpus uteri". J. Epidemiol. Biostat., 2001, 6, 47.
8. Mendivil A., Schuler K.M., Gehrig P.A.: "Non-endometrioid adenocarcinoma of the uterine corpus: a review of selected histological subtypes". Cancer Control, 2009, 16, 46.
9. Kay S.: "Clear cell carcinoma of the endometrium". Cancer, 1957, 10, 124.
10. Murphy K.T., Rotmensch J., Yamada S.D., Mundt A.J.: "Outcome and patterns of failure in pathologic Stages I-IV clear-cell carcinoma of the endometrium: implications for adjuvant radiation therapy". Int. J. Radiat. Oncol. Biol. Phys., 2003, 55, 1272. (Pubitemid 36338293)
11. Carcangiu M.L., Chambers J.T.: "Early pathologic stage clear cell carcinoma and uterine papillary serous carcinoma of the endometrium: comparison of clinicopathologic features and survival". Int. J. Gynecol. Pathol., 1995, 14, 30.
12. Malpica A., Tornos C., Burke T.W., Silva E.G.: "Low-stage clear cell carcinoma of the endometrium". Am. J. Surg. Pathol., 1995, 19, 769.
13. Smith R.S., Kapp D.S., Chen Q., Teng N.N.: "Treatment of high-risk uterine cancer with whole abdominopelvic radiation therapy". Int. J. Radiat. Oncol. Biol. Phys., 2000, 48, 767.
14. Martinez A.A., Weiner S., Podratz K., Armin A.R., Stromberg J.S., Stanhope R. et al.: "Improved outcome at 10 years for serous-papillary/ clear cell or high-risk endometrial cancer patients treated by adjuvant high-dose whole abdomino-pelvic irradiation". Gynecol. Oncol., 2003, 90, 537.
15. Alektiar K.M., McKee A., Lin O., Venkatraman E., Zelefsky M.J., McKee B. et al.: "Is there a difference in outcome between Stage I-II endometrial cancer of papillary serous/clear cell and endometrioid FIGO Grade 3 cancer?". Int. J. Radiat. Oncol. Biol. Phys., 2002, 54, 79.